EPIDEMIOLOGY, ETIOPATHOGENESIS, AND HEMOSTASIS PROCEDURES IN RECURRENT EPISTAXIS

Objective: To examine the literature on epidemiology, etiology, and treatment strategies for recurrent nosebleeds (RNB, epistaxis). Methods: Using information portals and platforms, including Elibrary.ru, PubMed, Web of Science, and Cochrane.org, we searched for specific keywords related to epistasi...

Full description

Saved in:
Bibliographic Details
Main Authors: O. NEMATZODA (Author), Z.A. AKHROROVA (Author), D.D. SULTANOV (Author), I. UBAYDULLO (Author)
Format: Book
Published: Avicenna Tajik State Medical University, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_37498f5fc92f41eba2a0ea3dce05eea2
042 |a dc 
100 1 0 |a O. NEMATZODA  |e author 
700 1 0 |a Z.A. AKHROROVA  |e author 
700 1 0 |a D.D. SULTANOV  |e author 
700 1 0 |a I. UBAYDULLO  |e author 
245 0 0 |a EPIDEMIOLOGY, ETIOPATHOGENESIS, AND HEMOSTASIS PROCEDURES IN RECURRENT EPISTAXIS 
260 |b Avicenna Tajik State Medical University,   |c 2024-03-01T00:00:00Z. 
500 |a 10.25005/2074-0581-2024-26-1-99-116 
500 |a 2074-0581 
500 |a 2959-6327 
520 |a Objective: To examine the literature on epidemiology, etiology, and treatment strategies for recurrent nosebleeds (RNB, epistaxis). Methods: Using information portals and platforms, including Elibrary.ru, PubMed, Web of Science, and Cochrane.org, we searched for specific keywords related to epistasis, including nosebleeds, recurrent nosebleeds, etiology, hemostasis methods, epistaxis, recurrent epistaxis, epidemiology, etiology, pathogenesis, treatment. We analyzed sixty-eight English and Russian scientific papers, excluding RNB articles on blood diseases, cancer, nasal injuries, and post-surgical interventions. Results: The prevalence rate of RNB remains unknown, with studies focusing on single institutions or regions. Epistasis relapse rates range from 5.9% to 30.5%, varying by cause and treatment methods. Most cases involve anterior epistaxis (90%), while 12.4% to 34.8% experience more severe posterior bleeding. Factors like arterial hypertension (AH), anticoagulant use, and environmental factors contribute to RNB. Severe cases may require hospitalization (6% to 8.2%), with 10.7% facing a third relapse needing vessel ligation or embolization. Around 0.25% to 4.8% of RNB patients may succumb due to complications or excessive bleeding. Conclusion: Research focused on understanding the reasons and procedures for treating RNB remains essential, as the condition can be life-threatening. Recurrence of epistaxis after different RNB treatments may require more extreme vessel-ligating surgeries. Therefore, improving treatment outcomes by adopting a personalized approach to selecting hemostasis methods and addressing the underlying causes of RNB is crucial. 
546 |a EN 
546 |a RU 
690 |a recurrent epistaxis 
690 |a etiology 
690 |a pathogenesis 
690 |a hemostasis methods 
690 |a nasal tamponade. 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Паёми Сино, Vol 26, Iss 1, Pp 99-116 (2024) 
787 0 |n https://doi.org/10.25005/2074-0581-2024-26-1-99-116 
787 0 |n https://doaj.org/toc/2074-0581 
787 0 |n https://doaj.org/toc/2959-6327 
856 4 1 |u https://doaj.org/article/37498f5fc92f41eba2a0ea3dce05eea2  |z Connect to this object online.